PKM and Hepatic fibrosis: Additionally, ex vivo studies have demonstrated that TEPP-46 can prevent hepatic stellate cell activation and the development of hepatic fibrosis by inducing PKM2 tetramerization, thereby inhibiting the progression of hepatic fibrosis [34].